Sharmila Rajan
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction, Fibroblast Growth Factor Research, Glycosylation and Glycoproteins Research, Protein purification and stability
Most-Cited Works
- → Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer(2019)196 cited
- → Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex(2015)107 cited
- → A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer(2012)105 cited
- → Discovery of a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR)(2013)65 cited
- → Production, characterization, andin vivohalf-life extension of polymeric IgA molecules in mice(2019)57 cited
- → Immune repertoire mining for rapid affinity optimization of mouse monoclonal antibodies(2019)31 cited
- → Effect of molecular size on interstitial pharmacokinetics and tissue catabolism of antibodies(2022)21 cited
- → Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO)(2024)17 cited
- → Generation and characterization of neutralizing monoclonal antibodies against baculo-expressed HPV 16 VLPs(2014)9 cited
- → Preclinical pharmacokinetic characterization of an adipose tissue-targeting monoclonal antibody in obese and non-obese animals(2017)7 cited